Intrapericardial lead with distal region configured to optimize lead extraction

• US 8,086,324 B1
• Filed: 09/27/2007
• Issued: 12/27/2011
• Est. Priority Date: 09/27/2007
• Status: Active Grant

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Inventors: Vase, Abhi
• Primary Examiner(s): Layno, Carl H
• Assistant Examiner(s): Patel, Natasha
• Application Number:
  US11/863,030
• Time in Patent Office: 1,552 Days
• Field of Search: 607/38, 607/125, 607/126
• US Class Current: 607/125
• CPC Class Codes: A61N 1/0587 Epicardial electrode systems; Endocardial electrodes piercing the pericardium
• CPC Class Codes: A61N 1/059 Anchoring means

Abstract

A lead includes a lead body with a stylet receiving lumen, a distal tip, and a distal portion proximal of the distal tip that is biased to assume a non-linear configuration. Insertion of a stylet into the lumen causes the distal portion to transition from the non-linear configuration to a generally linear configuration. The lead also includes a first arm member having a distal end and a proximal end coupled to the lead body proximal of the distal tip; and a nosepiece, at least a portion of which is biodegradable. The nosepiece is configured to receive the distal tip of the lead body and the distal end of the first arm member such that the lead body, first arm member and nosepiece form a closed arrangement prior to biodegradation of the nosepiece and an open arrangement after biodegradation of the nosepiece.

Claims

1. An intrapericardial lead for delivery via a percutaneous puncture and configurable by insertion of a stylet into the lead, the lead comprising:

a lead body including a stylet receiving lumen, a distal tip, and a distal portion proximal of the distal tip and biased to assume a non-linear configuration, wherein insertion of the stylet into the lumen such that the distal tip is distally displaced relative to the rest of the lead body causes the distal portion to transition from the non-linear configuration to a generally linear configuration;

a first arm member having a distal end, and a proximal end coupled to the lead body proximal of the distal tip; and

a nosepiece, at least a portion of which is biodegradable, having a first leg defining a first lumen opening configured to receive the distal tip of the lead body and a second leg defining a second lumen opening configured to receive the distal end of the first arm member, wherein the first leg and the second leg obliquely intersect such that the lead body, first arm member and nosepiece form a closed arrangement prior to biodegradation of the nosepiece and an open arrangement after biodegradation of the nosepiece, wherein in the closed arrangement the lead body and the first arm have non-uniform spacing there between along their respective lengths, and wherein the biodegradable portion of the nosepiece is configured to degrade to allow for the open arrangement after a time sufficient to allow for chronic fixation of the lead.

2. The lead of claim 1, wherein at least a portion of the nosepiece is formed of a biodegradable or bioabsorbable polymer.

3. The lead of claim 2, wherein the polymer includes collagen based polymer.

4. The lead of claim 2, wherein the polymer includes a polymer belonging to at least one of the families of polylactic acid (“

PLA”

) and polyglycolic acid (“

PGA”

).

5. The lead of claim 2, wherein the polymer includes polycaprolactone.

6. The lead of claim 1 wherein the entire nosepiece is biodegradable.

7. The lead of claim 1 wherein the nosepiece comprises a biodegradable segment between the distal tip of the lead body and the distal end of the first arm member.

8. The lead of claim 1, further comprising a second arm member having a distal end, and a proximal end coupled to the lead body proximal of the distal tip, wherein the nosepiece is further includes a third leg defining a third lumen opening configured to receive the distal end of the second arm member such that the lead body, first arm member, second arm member and nosepiece form a closed arrangement prior to biodegradation of the nosepiece and an open arrangement after biodegradation of the nosepiece.

9. The lead of claim 8, wherein the first leg and the third leg obliquely intersect.

10. The lead of claim 8, wherein the second and third legs extend along the arm members a distance of between approximately 1.5 to approximately five times the length of the first leg.

11. The lead of claim 1 wherein the biodegradable portion of the nosepiece is configured to begin degrading after a period within a patient of between approximately four weeks to approximately six weeks.

12. The lead of claim 1 wherein the biodegradable portion of the nosepiece is configured to be completely degraded over a period within a patient of between approximately six weeks to approximately fifteen weeks.

13. The lead of claim 1 wherein the first leg is formed of a non-biodegradable material and the second leg is formed at least partially of a biodegradable or bioabsorbable polymer.

14. The lead of claim 13 wherein the second leg comprises a portion that is formed of a non-biodegradable material.

15. A lead comprising:

a lead body including a distal tip, and a distal portion proximal of the distal tip;

a first arm member having a distal end, and a proximal end coupled to the lead body proximal of the distal tip; and

a nosepiece, at least a portion of which is biodegradable, having a first leg defining first lumen opening configured to receive the distal tip of the lead body and a second leg defining a second lumen opening configured to receive the distal end of the first arm member, wherein the first leg and the second leg obliquely intersect such that the lead body, first arm member and nosepiece form a closed arrangement prior to biodegradation of the nosepiece and an open arrangement after biodegradation of the nosepiece, wherein in the closed arrangement the lead body and the first arm have non-uniform spacing there between along their respective lengths, and wherein the biodegradable portion of the nosepiece is configured to degrade to allow for the open arrangement after a time sufficient to allow for chronic fixation of the lead.

16. The lead of claim 15 further comprising a fixation member mounted on the lead body and including a biodegradable portion.

17. The lead of claim 16, wherein the fixation member includes an element radially projecting outward from the lead body.

18. The lead of claim 17, wherein the element also projects distally.

19. The lead of claim 17, wherein the element is biased to expand away from the lead body.

20. The lead of claim 17, wherein the element comprises the biodegradable portion.

21. The lead of claim 16, wherein the biodegradable portion is a biodegradable or bioabsorbable polymer.

22. The lead of claim 21, wherein the polymer includes collagen based polymer.